We are currently recruiting study patients to be enrolled in a phase 1 trial for rilonacept.  Rilonacept is an FDA approved medication that can affect your immune system.  The hope is that using this medication in early type 1 diabetes, more of your insulin production can be saved.  If you're interested, please contact us.

To see if you qualify for one of our clinical trials, please contact us. 

This trial is open to patients with thyroid nodules and examines how a new gene expression test affects clinical decisions.  If you're interested, Contact Us.

The personnel at TED have considerable experience in Phase II-IV clinical trials and investigator initiated trials.  If you would like to take advantage of our expert personnel and ideal location contact us today.